The ingredient maker says it surveyed people on GLP-1 drugs about their beauty needs. It's a company marketing post with few findings shared.
Recap by typeshit. Post by Facebook on Facebook.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
The VeggieFest session on Saturday, October 17 at 10:30 AM looks at what else people may lose on GLP-1s besides fat. Entry is free and includes a vegetarian lunch.
A Facebook post says rapid weight loss on these drugs can raise gallstone risk, and lists warning signs like severe upper belly pain, fever and yellow eyes.
Loading…